{"id":10217,"date":"2026-07-15T09:56:14","date_gmt":"2026-07-15T07:56:14","guid":{"rendered":"https:\/\/cleanpeptides.eu\/ghk-cu-doseringsguide\/"},"modified":"2026-07-15T09:56:14","modified_gmt":"2026-07-15T07:56:14","slug":"ghk-cu-doseringsguide","status":"publish","type":"page","link":"https:\/\/cleanpeptides.eu\/da\/ghk-cu-doseringsguide\/","title":{"rendered":"GHK-Cu doseringsguide: injicerbar, topisk og kure"},"content":{"rendered":"<p class=\"wp-block-paragraph\"><em>Kobberpeptid GHK-Cu \u2014 injicerbar og topisk dosering, rekonstituering, kombination med BPC-157, cyklus og sikkerhed. Kun til forskningsform\u00e5l \u2014 ikke til human brug.<\/em><\/p>\n<p class=\"wp-block-paragraph\">Clean Peptides giver ikke r\u00e5dgivning om dosering eller anvendelse. Denne guide samler produktinformation fra Clean Peptides sammen med uafh\u00e6ngigt undervisningsmateriale fra PeptideWiki, kun som forskningsreference. Det er ikke medicinsk r\u00e5dgivning og udg\u00f8r hverken anbefalinger, godkendelser eller instruktioner fra Clean Peptides.<\/p>\n<h2 class=\"wp-block-heading\">Hvad er GHK-Cu?<\/h2>\n<p class=\"wp-block-paragraph\">GHK-Cu (glycyl-L-histidyl-L-lysin:kobber(II)) er et naturligt forekommende tripeptid med h\u00f8j affinitet for kobber(II)-ioner, f\u00f8rste gang isoleret fra humant plasma af dr. Loren Pickart i 1973. Det har over 60 publicerede studier inden for s\u00e5rheling, kollagensyntese, anti-aging og v\u00e6vsremodellering. Unikt har det etablerede protokoller for b\u00e5de injicerbar (systemisk heling) og topisk (lokaliseret hudforyngelse) brug.<\/p>\n<p class=\"wp-block-paragraph\">Injicerbar dosering stammer fra dyrefors\u00f8g, forskning i plasmakoncentration og protokoller fra f\u00e6llesskabet; den topiske underst\u00f8ttes af humane hudstudier.<\/p>\n<h2 class=\"wp-block-heading\">N\u00f8gleegenskaber<\/h2>\n<ul class=\"wp-block-list\">\n<li>Naturligt forekommende \u2014 falder med alderen (200 ng\/mL i ungdommen \u2192 80 ng\/mL ved 60-\u00e5rsalderen).<\/li>\n<li>Kobberlevering \u2014 essentiel kofaktor for reparationsenzymer (SOD, lysyloxidase).<\/li>\n<li>Kollagensyntese \u2014 stimulerer kollagen I og III, decorin, elastin, glykosaminoglykaner.<\/li>\n<li>S\u00e5rheling \u2014 accelererer lukning, tiltr\u00e6kker immunceller, fremmer angiogenese.<\/li>\n<li>Antiinflammatorisk \u2014 nedregulerer TNF-alfa og IL-6.<\/li>\n<li>Genmodulering \u2014 p\u00e5virker ekspressionen af omkring 4000 gener mod en sundere profil.<\/li>\n<li>Dobbelt vej \u2014 effektiv b\u00e5de systemisk (injicerbar) og lokalt (topisk).<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">S\u00e5dan fastl\u00e6gges doseringen<\/h2>\n<p class=\"wp-block-paragraph\">Baseret p\u00e5 \u00e5rtiers forskning: topiske studier i mennesker, injicerbare studier i dyr\/cellekulturer og plasmakoncentrationsdata. Den injicerbare dosis p\u00e5 1\u20132 mg\/dag SC opstod fra behandleres og f\u00e6llesskabets erfaring. Evidensstyrke: st\u00e6rk for topisk, moderat for injicerbar.<\/p>\n<h2 class=\"wp-block-heading\">Injicerbare doseringsintervaller<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Niveau<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Dosis\/injektion<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Hyppighed<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Dagligt total<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Konservativ<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0,5 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">En gang dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0,5 mg\/dag<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Standard<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1,0 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">En gang dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1,0 mg\/dag<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Aggressiv<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2,0 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">En gang dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">2,0 mg\/dag<\/td>\n<\/tr>\n<\/table>\n<p class=\"wp-block-paragraph\">De fleste starter med 1,0 mg en gang dagligt. 2,0 mg-dosen er forbeholdt akut s\u00e5rheling\/postoperative protokoller. H\u00f8jere doser giver ikke proportionalt bedre resultater.<\/p>\n<h2 class=\"wp-block-heading\">Topiske protokoller<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Formulering<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Koncentration<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Hyppighed<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">P\u00e5f\u00f8ringsomr\u00e5de<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Serum<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u20132 % GHK-Cu<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u20132\u00d7 dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Ansigt, hals, m\u00e5lomr\u00e5der<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Creme<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0,5\u20131 % GHK-Cu<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u20132\u00d7 dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Ansigt, krop, s\u00e5r<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Individuel (magistrel)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u20133 % GHK-Cu<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u20132\u00d7 dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Efter behandlerens anvisning<\/td>\n<\/tr>\n<\/table>\n<p class=\"wp-block-paragraph\">P\u00e5f\u00f8r p\u00e5 ren hud f\u00f8r tungere cremer. V\u00e6r konsekvent i 4\u20138 uger, f\u00f8r du vurderer. Ingen cyklus n\u00f8dvendig. Undg\u00e5 at l\u00e6gge sammen med st\u00e6rke syrer eller L-ascorbinsyre (C-vitamin), som destabiliserer kobberpeptidet. Lav f\u00f8rst en pletpr\u00f8ve.<\/p>\n<h2 class=\"wp-block-heading\">Rekonstituering og dosering (med de medf\u00f8lgende 3 mL)<\/h2>\n<p class=\"wp-block-paragraph\">Hvert Clean Peptides-h\u00e6tteglas leveres med 3 mL bakteriostatisk vand (0,9 % benzylalkohol). Alle tal nedenfor foruds\u00e6tter rekonstituering med de fulde 3 mL. P\u00e5 en standard U-100-insulinspr\u00f8jte er 100 enheder = 1 mL. Hurtig formel: koncentration = h\u00e6tteglasstyrke \u00f7 3 mL, og enheder at tr\u00e6kke op = dosis (mg) \u00d7 300 \u00f7 h\u00e6tteglasstyrke (mg).<\/p>\n<h3 class=\"wp-block-heading\">S\u00e5dan rekonstitueres<\/h3>\n<ol class=\"wp-block-list\">\n<li>Vask h\u00e6nderne og l\u00e6g h\u00e6tteglasset, de 3 mL bakteriostatisk vand, en insulinspr\u00f8jte og spritservietter frem p\u00e5 en ren overflade.<\/li>\n<li>Vip h\u00e6tterne af og aft\u00f8r begge gummipropper med sprit; lad dem luftt\u00f8rre 10\u201315 sekunder.<\/li>\n<li>Tr\u00e6k de fulde 3 mL bakteriostatisk vand op (i tre 1 mL-omgange med en insulinspr\u00f8jte eller i \u00e9n omgang med en 3 mL-spr\u00f8jte).<\/li>\n<li>Tils\u00e6t vandet langsomt, og vinkl n\u00e5len, s\u00e5 det l\u00f8ber ned ad den indvendige glasv\u00e6g \u2014 spr\u00f8jt det aldrig direkte p\u00e5 pulveret.<\/li>\n<li>Opl\u00f8s forsigtigt \u2014 lad h\u00e6tteglasset st\u00e5 1\u20132 minutter, og hvirvl eller rul det derefter mellem h\u00e5ndfladerne, til opl\u00f8sningen er klar. En bl\u00e5\/gr\u00f8n farve er normal. Ryst aldrig.<\/li>\n<li>M\u00e6rk og opbevar i k\u00f8leskab ved 2\u20138 \u00b0C. Resulterende koncentration: 50 mg \u2192 16,67 mg\/mL; 100 mg \u2192 33,33 mg\/mL.<\/li>\n<\/ol>\n<p class=\"wp-block-paragraph\"><strong>Opbevaring:<\/strong> ikke-rekonstitueret pulver i k\u00f8leskab (2\u20138 \u00b0C); rekonstitueret opl\u00f8sning i k\u00f8leskab og anvendt inden for 28\u201330 dage; m\u00e5 ikke fryses; beskyt mod lys og varme.<\/p>\n<h3 class=\"wp-block-heading\">Optr\u00e6ksvolumener med 3 mL \u2014 GHK-Cu<\/h3>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">H\u00e6tteglas (Clean Peptides)<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Koncentration<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">0,5 mg<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">1 mg<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">2 mg<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">50 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">16,67 mg\/mL<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">3 e<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">6 e<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">12 e<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">100 mg<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">33,33 mg\/mL<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1,5 e<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">3 e<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">6 e<\/td>\n<\/tr>\n<\/table>\n<h2 class=\"wp-block-heading\">Dosering efter m\u00e5l<\/h2>\n<ul class=\"wp-block-list\">\n<li><strong>Hudforyngelse og anti-aging:<\/strong> injicerbar 1,0 mg\/dag \u00d7 4\u20138 uger + topisk serum 1\u20132 % 2\u00d7 dagligt l\u00f8bende.<\/li>\n<li><strong>S\u00e5rheling og postoperativt:<\/strong> injicerbar 1\u20132 mg\/dag \u00d7 2\u20134 uger; topisk n\u00e5r granulationen begynder. Ofte kombineret med BPC-157.<\/li>\n<li><strong>H\u00e5rv\u00e6kst:<\/strong> topisk 1\u20132 % p\u00e5 hovedbunden dagligt + injicerbar 1,0 mg\/dag \u00d7 8\u201312 uger.<\/li>\n<li><strong>Systemisk antiinflammatorisk og v\u00e6vsreparation:<\/strong> injicerbar 1\u20132 mg\/dag \u00d7 4\u20138 uger; ofte med BPC-157.<\/li>\n<\/ul>\n<p class=\"wp-block-paragraph\">Til kosmetiske hudm\u00e5l har den topiske den st\u00e6rkeste humane evidens; den injicerbare foretr\u00e6kkes til systemiske\/postoperative m\u00e5l.<\/p>\n<h2 class=\"wp-block-heading\">Injektionsguide<\/h2>\n<ol class=\"wp-block-list\">\n<li>Vask h\u00e6nderne og klarg\u00f8r.<\/li>\n<li>Aft\u00f8r proppen; lad den luftt\u00f8rre.<\/li>\n<li>Tr\u00e6k dosis op (en let bl\u00e5\/gr\u00f8n tone er normal); bank bobler ud.<\/li>\n<li>V\u00e6lg sted \u2014 mave (5 cm fra navlen) eller forsiden af l\u00e5ret; skift dagligt.<\/li>\n<li>Rens stedet; lad det luftt\u00f8rre.<\/li>\n<li>Injicer i en l\u00f8ftet hudfold i 45\u00b0.<\/li>\n<li>Bortskaf i en kanyleb\u00f8tte.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Kurvarighed og timing<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Protokol<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Varighed<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Bedst til<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Standard injicerbar kur<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4\u20138 ugers brug, 4 ugers pause<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Hudforyngelse, generel heling, antiinflammation<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Forl\u00e6nget injicerbar kur<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">8\u201312 ugers brug, 4 ugers pause<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">H\u00e5rv\u00e6kst, kronisk s\u00e5rheling<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Topisk (l\u00f8bende)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">L\u00f8bende \u2014 ingen cyklus<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Daglig hudpleje, kosmetisk vedligeholdelse<\/td>\n<\/tr>\n<\/table>\n<h2 class=\"wp-block-heading\">Kombinationsprotokoller<\/h2>\n<p class=\"wp-block-paragraph\"><strong>GHK-Cu + BPC-157 (omfattende helingskombination):<\/strong><\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:1em 0;\">\n<tr>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Stof<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Dosis<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Hyppighed<\/th>\n<th style=\"background:#f4f4f4;border:1px solid #ddd;padding:8px;text-align:left;\">Form\u00e5l<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">GHK-Cu<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">1\u20132 mg SC<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">En gang dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Kollagensyntese, v\u00e6vsremodellering<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">BPC-157<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">250\u2013500 mcg SC<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">En\/to gange dagligt<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Angiogenese, v\u00e6kstfaktorer, lokal reparation<\/td>\n<\/tr>\n<\/table>\n<p class=\"wp-block-paragraph\">Fulde BPC-157-protokoller: se vores <a href=\"https:\/\/cleanpeptides.eu\/da\/bpc-157-doseringsguide\/\">BPC-157-doseringsguide<\/a>. GHK-Cu + thymosin alpha-1 (immun- + reparationskombination): GHK-Cu 1 mg SC dagligt + thymosin alpha-1 1,6 mg SC 2\u20133\u00d7\/uge.<\/p>\n<h2 class=\"wp-block-heading\">Sikkerhed, bivirkninger og kontraindikationer<\/h2>\n<p class=\"wp-block-paragraph\">Gunstig sikkerhedsprofil gennem \u00e5rtier; den topiske bruges bredt i h\u00e5ndk\u00f8bskosmetik.<\/p>\n<p class=\"wp-block-paragraph\"><strong>Bivirkninger ved injicerbar (milde, forbig\u00e5ende):<\/strong> irritation\/r\u00f8dme ved injektionsstedet, lejlighedsvis hovedpine, sj\u00e6lden kvalme. <strong>Topisk:<\/strong> lejlighedsvis let irritation; sj\u00e6lden kontaktoverf\u00f8lsomhed.<\/p>\n<p class=\"wp-block-paragraph\"><strong>Kontraindikationer:<\/strong> aktiv kr\u00e6ft eller tidligere kr\u00e6ft; Wilsons sygdom eller forstyrrelser i kobberstofskiftet; graviditet og amning; kobberallergi.<\/p>\n<p class=\"wp-block-paragraph\">Regulatorisk: den injicerbare er ikke FDA-godkendt (forskningspeptid); den topiske er reguleret som en kosmetisk ingrediens; aktuelt ikke forbudt af WADA (verific\u00e9r).<\/p>\n<h2 class=\"wp-block-heading\">Almindelige fejl<\/h2>\n<ul class=\"wp-block-list\">\n<li>At bruge GHK-Cu af topisk kvalitet til injektion (kun steril injicerbar kvalitet til SC).<\/li>\n<li>At forvente topiske resultater fra dag til dag (der kr\u00e6ves 4\u20138 uger).<\/li>\n<li>At p\u00e5f\u00f8re topisk p\u00e5 \u00e5bne s\u00e5r for tidligt.<\/li>\n<li>At kassere h\u00e6tteglasset, fordi det ser bl\u00e5t\/gr\u00f8nt ud (det er normalt).<\/li>\n<li>At k\u00f8re injicerbare doser over 2 mg\/dag.<\/li>\n<li>Ikke at cykle injicerbar brug.<\/li>\n<li>At l\u00e6gge sammen med uforenelige aktive stoffer (AHA\/BHA, C-vitamin).<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Hovedpunkter<\/h2>\n<ul class=\"wp-block-list\">\n<li>Dobbeltvejs-peptid: injicerbar 1\u20132 mg\/dag SC og topisk serum 1\u20132 %.<\/li>\n<li>Falder naturligt med alderen; stimulerer kollagen I\/III, elastin og glykosaminoglykaner.<\/li>\n<li>Den bl\u00e5\/gr\u00f8nne farve efter rekonstituering er normal (kobber II).<\/li>\n<li>Injicerbar kur 4\u20138 ugers brug \/ 4 ugers pause; topisk l\u00f8bende.<\/li>\n<li>Bedste kombination GHK-Cu + BPC-157; kontraindiceret ved kobberforstyrrelser, aktiv kr\u00e6ft, graviditet.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Referencer<\/h2>\n<ol class=\"wp-block-list\">\n<li>Pickart L. &#8220;The human tri-peptide GHK and tissue remodeling.&#8221; J Biomater Sci Polym Ed. 2008;19(8):969-988.<\/li>\n<li>Pickart L, Margolina A. &#8220;Regenerative and protective actions of the GHK-Cu peptide.&#8221; Int J Mol Sci. 2018;19(7):1987.<\/li>\n<li>Maquart FX, et al. &#8220;Stimulation of collagen synthesis by GHK-Cu\u00b2\u207a.&#8221; FEBS Lett. 1988;238(2):343-346.<\/li>\n<li>Leyden J, et al. &#8220;Facial skin rejuvenation by copper peptide cream.&#8221; J Cosmet Dermatol. 2002;1(Suppl 1):S17.<\/li>\n<li>Pollard JD, et al. &#8220;Synthetic GHK-Cu promotes healing of segmental bone defects.&#8221; J Bone Joint Surg Am. 2005;87(Suppl 2):57-63.<\/li>\n<\/ol>\n<h2 class=\"wp-block-heading\">Download og relaterede ressourcer<\/h2>\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/cleanpeptides.eu\/wp-content\/uploads\/2026\/07\/04-GHK-Cu-Dosage-Guide-Clean-Peptides.pdf\" target=\"_blank\" rel=\"noopener\">\ud83d\udcc4 Download PDF-guide<\/a><\/p>\n<p class=\"wp-block-paragraph\">K\u00f8b GHK-Cu: <a href=\"https:\/\/cleanpeptides.eu\/product\/ghk-cu-100-mg\/\">GHK-Cu 100 mg<\/a> \u00b7 <a href=\"https:\/\/cleanpeptides.eu\/product\/ghk-cu-50-mg\/\">GHK-Cu 50 mg<\/a><\/p>\n\n    <div class=\"xs_social_share_widget xs_share_url after_content \t\tmain_content  wslu-style-1 wslu-share-box-shaped wslu-fill-colored wslu-none wslu-share-horizontal wslu-theme-font-no wslu-main_content\">\n\n\t\t\n        <ul>\n\t\t\t        <\/ul>\n    <\/div> \n","protected":false},"excerpt":{"rendered":"<p>Kobberpeptid GHK-Cu \u2014 injicerbar og topisk dosering, rekonstituering, kombination med BPC-157, cyklus og sikkerhed. Kun til forskningsform\u00e5l \u2014 ikke til [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-10217","page","type-page","status-publish","hentry"],"_hostinger_reach_plugin_has_subscription_block":false,"_hostinger_reach_plugin_is_elementor":false,"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages\/10217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/comments?post=10217"}],"version-history":[{"count":0,"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/pages\/10217\/revisions"}],"wp:attachment":[{"href":"https:\/\/cleanpeptides.eu\/da\/wp-json\/wp\/v2\/media?parent=10217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}